Chronic versus acute effects of p53 deletion on Olig2 progenitor malignancy
p53 缺失对 Olig2 祖细胞恶性肿瘤的慢性与急性影响
基本信息
- 批准号:8529433
- 负责人:
- 金额:$ 8.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAdultAffectAgeAgingAnimal ModelBiological AssayBiological ModelsBrainCDKN2A geneCell physiologyCellsChronicDNADataDevelopmentDown-RegulationEngineeringExposure toFutureGenomic InstabilityGliomaGliomagenesisHumanHypoxiaIn VitroIncidenceIntrinsic factorLinkLittle&aposs DiseaseLongevityMalignant - descriptorMalignant NeoplasmsModelingMolecularMusMutationNeurobiologyOutcomePathogenesisPatientsPopulationPre-Clinical ModelPrognostic FactorPropertyReagentReportingResearchResidual stateResistanceRiskSystemTamoxifenTestingTimeTumor Suppressor ProteinsValidationage effectage relatedagedanimal model developmentbasefollow-upimplantationin vivoinnovationmalignant phenotypemalignant statemouse modelnerve stem cellnervous system disordernovelprogenitorrecombinasetooltreatment responsetumor
项目摘要
DESCRIPTION (provided by applicant): Human gliomas are a nearly uniformly fatal disease and little improvement in outcome has been realized in over 25 years. Although arguably the most important prognostic factor for glioma risk, survival, malignancy and treatment resistance, aging has not been incorporated into routine pre-clinical models and the underlying mechanisms responsible for the negative effects of aging are not known. Here we propose to follow up on our previous novel observation that glioma malignancy in a mouse model is primarily dependent on age-related cell intrinsic factors. Among potential candidate mechanisms, we discovered that a chronic decline in p53 activity with aging in neural progenitor cells (NPCs), associated with increased genomic instability, may in part account for this effect. Therefore we propose to develop a novel mouse model system whereby p53 can be deleted from Olig2 expressing NPCs after exposure to tamoxifen in a temporal fashion. This will permit the unambiguous determination of how chronic versus acute p53 deletion affects the malignant potential of Olig2 NPCs (putative glioma cells of origin) and associated effects on genomic instability. We expect to demonstrate that this versatile model system will facilitate validation of our hypothesis that chronic loss of p53 function, as occurs with aging, enhances genomic instability and malignant potential in NPCs. In keeping with the R03 mechanism, the completion of these self-contained studies will provide valuable new research tools and data for future studies of general importance in many fields of neurobiology and nervous system disease.
描述(由申请人提供):人类神经胶质瘤是一种几乎一致的致命性疾病,在过去25年中,几乎没有实现结局的改善。尽管可以说是胶质瘤风险、存活率、恶性程度和治疗抗性的最重要预后因素,但衰老尚未被纳入常规临床前模型,并且导致衰老负面影响的潜在机制尚不清楚。在这里,我们建议跟进我们以前的新的观察,神经胶质瘤恶性肿瘤的小鼠模型,主要是依赖于年龄相关的细胞内在因素。在潜在的候选机制中,我们发现神经祖细胞(NPC)中p53活性随着衰老而慢性下降,与基因组不稳定性增加相关,可能部分解释了这种效应。因此,我们建议开发一种新的小鼠模型系统,其中p53可以从Olig2表达NPC后,暴露于他莫昔芬在一个时间的方式删除。这将允许明确确定慢性与急性p53缺失如何影响Olig2 NPC(假定的神经胶质瘤细胞起源)的恶性潜能以及对基因组不稳定性的相关影响。我们希望证明,这种多功能的模型系统将有助于验证我们的假设,即p53功能的慢性丧失,随着年龄的增长,增强基因组的不稳定性和恶性潜能的NPC。与R03机制保持一致,这些独立研究的完成将为神经生物学和神经系统疾病许多领域的未来研究提供有价值的新研究工具和数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT C ROSTOMILY其他文献
ROBERT C ROSTOMILY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT C ROSTOMILY', 18)}}的其他基金
Therapeutically relevant targets of Twist1 dimers in glioma
神经胶质瘤中 Twist1 二聚体的治疗相关靶点
- 批准号:
8859923 - 财政年份:2015
- 资助金额:
$ 8.22万 - 项目类别:
Therapeutically relevant targets of Twist1 dimers in glioma
神经胶质瘤中 Twist1 二聚体的治疗相关靶点
- 批准号:
9011554 - 财政年份:2015
- 资助金额:
$ 8.22万 - 项目类别:
Therapeutically relevant targets of Twist1 dimers in glioma
神经胶质瘤中 Twist1 二聚体的治疗相关靶点
- 批准号:
9898473 - 财政年份:2015
- 资助金额:
$ 8.22万 - 项目类别:
Therapeutically relevant targets of Twist1 dimers in glioma
神经胶质瘤中 Twist1 二聚体的治疗相关靶点
- 批准号:
9513631 - 财政年份:2015
- 资助金额:
$ 8.22万 - 项目类别:
Chronic versus acute effects of p53 deletion on Olig2 progenitor malignancy
p53 缺失对 Olig2 祖细胞恶性肿瘤的慢性与急性影响
- 批准号:
8384516 - 财政年份:2012
- 资助金额:
$ 8.22万 - 项目类别:
TWIST1 as a target for inhibition of glioma invasion
TWIST1作为抑制神经胶质瘤侵袭的靶标
- 批准号:
8387046 - 财政年份:2011
- 资助金额:
$ 8.22万 - 项目类别:
TWIST1 as a target for inhibition of glioma invasion
TWIST1作为抑制神经胶质瘤侵袭的靶标
- 批准号:
8585038 - 财政年份:2011
- 资助金额:
$ 8.22万 - 项目类别:
TWIST1 as a target for inhibition of glioma invasion
TWIST1作为抑制神经胶质瘤侵袭的靶标
- 批准号:
8039228 - 财政年份:2011
- 资助金额:
$ 8.22万 - 项目类别:
TWIST1 as a target for inhibition of glioma invasion
TWIST1作为抑制神经胶质瘤侵袭的靶标
- 批准号:
8244998 - 财政年份:2011
- 资助金额:
$ 8.22万 - 项目类别:
Modeling gliomagenesis with aging glial progenitor cells and hosts
用衰老的神经胶质祖细胞和宿主模拟神经胶质瘤发生
- 批准号:
7313258 - 财政年份:2007
- 资助金额:
$ 8.22万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 8.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 8.22万 - 项目类别:
Standard Grant














{{item.name}}会员




